| UniProt ID | VDAC3_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y277 | |
| Protein Name | Voltage-dependent anion-selective channel protein 3 | |
| Gene Name | VDAC3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 283 | |
| Subcellular Localization | Mitochondrion outer membrane. | |
| Protein Description | Forms a channel through the mitochondrial outer membrane that allows diffusion of small hydrophilic molecules.. | |
| Protein Sequence | MCNTPTYCDLGKAAKDVFNKGYGFGMVKIDLKTKSCSGVEFSTSGHAYTDTGKASGNLETKYKVCNYGLTFTQKWNTDNTLGTEISWENKLAEGLKLTLDTIFVPNTGKKSGKLKASYKRDCFSVGSNVDIDFSGPTIYGWAVLAFEGWLAGYQMSFDTAKSKLSQNNFALGYKAADFQLHTHVNDGTEFGGSIYQKVNEKIETSINLAWTAGSNNTRFGIAAKYMLDCRTSLSAKVNNASLIGLGYTQTLRPGVKLTLSALIDGKNFSAGGHKVGLGFELEA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MCNTPTYCD ------CCCCCCCCC | 8.58 | 25944712 | |
| 4 | Phosphorylation | ----MCNTPTYCDLG ----CCCCCCCCCHH | 16.45 | 23401153 | |
| 6 | Phosphorylation | --MCNTPTYCDLGKA --CCCCCCCCCHHHH | 34.44 | 23663014 | |
| 7 | Phosphorylation | -MCNTPTYCDLGKAA -CCCCCCCCCHHHHH | 5.79 | 23663014 | |
| 12 | Acetylation | PTYCDLGKAAKDVFN CCCCCHHHHHHHHHH | 53.09 | 23749302 | |
| 12 | Ubiquitination | PTYCDLGKAAKDVFN CCCCCHHHHHHHHHH | 53.09 | 23000965 | |
| 12 | Malonylation | PTYCDLGKAAKDVFN CCCCCHHHHHHHHHH | 53.09 | 26320211 | |
| 15 | Acetylation | CDLGKAAKDVFNKGY CCHHHHHHHHHHCCC | 60.32 | 23749302 | |
| 15 | Ubiquitination | CDLGKAAKDVFNKGY CCHHHHHHHHHHCCC | 60.32 | 23000965 | |
| 15 | Malonylation | CDLGKAAKDVFNKGY CCHHHHHHHHHHCCC | 60.32 | 26320211 | |
| 20 | Acetylation | AAKDVFNKGYGFGMV HHHHHHHCCCCCEEE | 41.88 | 19608861 | |
| 20 | Succinylation | AAKDVFNKGYGFGMV HHHHHHHCCCCCEEE | 41.88 | - | |
| 20 | Ubiquitination | AAKDVFNKGYGFGMV HHHHHHHCCCCCEEE | 41.88 | 23000965 | |
| 20 (in isoform 2) | Ubiquitination | - | 41.88 | 21890473 | |
| 20 | Malonylation | AAKDVFNKGYGFGMV HHHHHHHCCCCCEEE | 41.88 | 26320211 | |
| 20 (in isoform 1) | Ubiquitination | - | 41.88 | 21890473 | |
| 21 | Ubiquitination | AKDVFNKGYGFGMVK HHHHHHCCCCCEEEE | 28.97 | 22817900 | |
| 22 | Phosphorylation | KDVFNKGYGFGMVKI HHHHHCCCCCEEEEE | 15.76 | - | |
| 28 | Acetylation | GYGFGMVKIDLKTKS CCCCEEEEEEECCCC | 22.93 | 19608861 | |
| 28 | Ubiquitination | GYGFGMVKIDLKTKS CCCCEEEEEEECCCC | 22.93 | 22817900 | |
| 28 | Malonylation | GYGFGMVKIDLKTKS CCCCEEEEEEECCCC | 22.93 | 26320211 | |
| 28 (in isoform 1) | Ubiquitination | - | 22.93 | 21890473 | |
| 28 (in isoform 2) | Ubiquitination | - | 22.93 | 21890473 | |
| 29 | Ubiquitination | YGFGMVKIDLKTKSC CCCEEEEEEECCCCC | 5.22 | 27667366 | |
| 32 | Ubiquitination | GMVKIDLKTKSCSGV EEEEEEECCCCCCCC | 50.59 | 22817900 | |
| 33 | Phosphorylation | MVKIDLKTKSCSGVE EEEEEECCCCCCCCE | 35.17 | 23312004 | |
| 34 | Ubiquitination | VKIDLKTKSCSGVEF EEEEECCCCCCCCEE | 48.13 | 33845483 | |
| 34 | Acetylation | VKIDLKTKSCSGVEF EEEEECCCCCCCCEE | 48.13 | 26051181 | |
| 35 | Phosphorylation | KIDLKTKSCSGVEFS EEEECCCCCCCCEEE | 20.81 | 26437602 | |
| 35 (in isoform 2) | Phosphorylation | - | 20.81 | 26437602 | |
| 37 | Phosphorylation | DLKTKSCSGVEFSTS EECCCCCCCCEEECC | 53.62 | 23312004 | |
| 42 | Phosphorylation | SCSGVEFSTSGHAYT CCCCCEEECCCEEEE | 14.25 | 28152594 | |
| 43 | Phosphorylation | CSGVEFSTSGHAYTD CCCCEEECCCEEEEC | 44.01 | 28152594 | |
| 43 (in isoform 2) | Phosphorylation | - | 44.01 | - | |
| 44 | Phosphorylation | SGVEFSTSGHAYTDT CCCEEECCCEEEECC | 27.64 | 28152594 | |
| 44 (in isoform 2) | Phosphorylation | - | 27.64 | - | |
| 45 (in isoform 2) | Phosphorylation | - | 14.99 | 20833797 | |
| 48 | Phosphorylation | FSTSGHAYTDTGKAS EECCCEEEECCCCCC | 10.24 | 28152594 | |
| 49 | Phosphorylation | STSGHAYTDTGKASG ECCCEEEECCCCCCC | 28.06 | 28152594 | |
| 49 (in isoform 2) | Phosphorylation | - | 28.06 | 26437602 | |
| 50 (in isoform 2) | Phosphorylation | - | 40.56 | - | |
| 51 | Phosphorylation | SGHAYTDTGKASGNL CCEEEECCCCCCCCC | 32.55 | 28152594 | |
| 53 | Ubiquitination | HAYTDTGKASGNLET EEEECCCCCCCCCCC | 41.28 | 21906983 | |
| 53 | Neddylation | HAYTDTGKASGNLET EEEECCCCCCCCCCC | 41.28 | 32015554 | |
| 53 | Acetylation | HAYTDTGKASGNLET EEEECCCCCCCCCCC | 41.28 | 26051181 | |
| 53 (in isoform 1) | Ubiquitination | - | 41.28 | 21890473 | |
| 54 | Ubiquitination | AYTDTGKASGNLETK EEECCCCCCCCCCCE | 24.82 | 22817900 | |
| 55 | Phosphorylation | YTDTGKASGNLETKY EECCCCCCCCCCCEE | 31.53 | 26437602 | |
| 56 (in isoform 2) | Phosphorylation | - | 47.83 | 26437602 | |
| 61 | Acetylation | ASGNLETKYKVCNYG CCCCCCCEEEEECCC | 33.43 | 25825284 | |
| 61 | Ubiquitination | ASGNLETKYKVCNYG CCCCCCCEEEEECCC | 33.43 | 25621951 | |
| 62 | Ubiquitination | SGNLETKYKVCNYGL CCCCCCEEEEECCCC | 18.97 | 32142685 | |
| 62 | Phosphorylation | SGNLETKYKVCNYGL CCCCCCEEEEECCCC | 18.97 | 29496907 | |
| 62 | Acetylation | SGNLETKYKVCNYGL CCCCCCEEEEECCCC | 18.97 | 19608861 | |
| 63 | Acetylation | GNLETKYKVCNYGLT CCCCCEEEEECCCCE | 41.70 | 23954790 | |
| 63 | Ubiquitination | GNLETKYKVCNYGLT CCCCCEEEEECCCCE | 41.70 | 33845483 | |
| 63 | Malonylation | GNLETKYKVCNYGLT CCCCCEEEEECCCCE | 41.70 | 26320211 | |
| 64 | Ubiquitination | NLETKYKVCNYGLTF CCCCEEEEECCCCEE | 2.02 | 33845483 | |
| 64 | Acetylation | NLETKYKVCNYGLTF CCCCEEEEECCCCEE | 2.02 | 19608861 | |
| 65 | S-nitrosocysteine | LETKYKVCNYGLTFT CCCEEEEECCCCEEE | 2.58 | - | |
| 65 | S-nitrosylation | LETKYKVCNYGLTFT CCCEEEEECCCCEEE | 2.58 | 20140087 | |
| 67 | Phosphorylation | TKYKVCNYGLTFTQK CEEEEECCCCEEEEE | 14.37 | 28152594 | |
| 70 | Phosphorylation | KVCNYGLTFTQKWNT EEECCCCEEEEEECC | 21.92 | 28152594 | |
| 72 | Phosphorylation | CNYGLTFTQKWNTDN ECCCCEEEEEECCCC | 24.81 | 28152594 | |
| 77 | Ubiquitination | TFTQKWNTDNTLGTE EEEEEECCCCCCCCE | 29.52 | 21890473 | |
| 78 | Ubiquitination | FTQKWNTDNTLGTEI EEEEECCCCCCCCEE | 42.79 | 22817900 | |
| 81 | Ubiquitination | KWNTDNTLGTEISWE EECCCCCCCCEEEEC | 11.37 | 22817900 | |
| 83 | Ubiquitination | NTDNTLGTEISWENK CCCCCCCCEEEECHH | 33.00 | 27667366 | |
| 86 | Phosphorylation | NTLGTEISWENKLAE CCCCCEEEECHHHHH | 23.31 | 30387612 | |
| 90 | Acetylation | TEISWENKLAEGLKL CEEEECHHHHHCCEE | 37.24 | 19608861 | |
| 90 | Ubiquitination | TEISWENKLAEGLKL CEEEECHHHHHCCEE | 37.24 | 29967540 | |
| 91 | Ubiquitination | EISWENKLAEGLKLT EEEECHHHHHCCEEE | 8.71 | 29967540 | |
| 91 | Acetylation | EISWENKLAEGLKLT EEEECHHHHHCCEEE | 8.71 | 19608861 | |
| 96 | Acetylation | NKLAEGLKLTLDTIF HHHHHCCEEEEEEEE | 50.73 | 25953088 | |
| 98 | Phosphorylation | LAEGLKLTLDTIFVP HHHCCEEEEEEEECC | 22.47 | 24641631 | |
| 107 | Phosphorylation | DTIFVPNTGKKSGKL EEEECCCCCCCCCCE | 44.29 | 28555341 | |
| 109 | Acetylation | IFVPNTGKKSGKLKA EECCCCCCCCCCEEE | 41.55 | 25953088 | |
| 109 | Ubiquitination | IFVPNTGKKSGKLKA EECCCCCCCCCCEEE | 41.55 | 21906983 | |
| 109 | Malonylation | IFVPNTGKKSGKLKA EECCCCCCCCCCEEE | 41.55 | 26320211 | |
| 109 (in isoform 1) | Ubiquitination | - | 41.55 | 21890473 | |
| 110 | Acetylation | FVPNTGKKSGKLKAS ECCCCCCCCCCEEEE | 66.83 | 30583797 | |
| 110 | Ubiquitination | FVPNTGKKSGKLKAS ECCCCCCCCCCEEEE | 66.83 | 32142685 | |
| 110 (in isoform 2) | Ubiquitination | - | 66.83 | 21890473 | |
| 111 | Ubiquitination | VPNTGKKSGKLKASY CCCCCCCCCCEEEEE | 44.65 | 22817900 | |
| 113 | Acetylation | NTGKKSGKLKASYKR CCCCCCCCEEEEEEC | 54.64 | 30583803 | |
| 113 | Ubiquitination | NTGKKSGKLKASYKR CCCCCCCCEEEEEEC | 54.64 | 22817900 | |
| 114 | Ubiquitination | TGKKSGKLKASYKRD CCCCCCCEEEEEECC | 6.81 | 22817900 | |
| 115 | Acetylation | GKKSGKLKASYKRDC CCCCCCEEEEEECCC | 38.48 | 7706155 | |
| 115 | Ubiquitination | GKKSGKLKASYKRDC CCCCCCEEEEEECCC | 38.48 | 27667366 | |
| 116 | Ubiquitination | KKSGKLKASYKRDCF CCCCCEEEEEECCCE | 28.64 | 27667366 | |
| 117 | Phosphorylation | KSGKLKASYKRDCFS CCCCEEEEEECCCEE | 29.60 | 26437602 | |
| 119 | Acetylation | GKLKASYKRDCFSVG CCEEEEEECCCEECC | 38.99 | 25953088 | |
| 124 | Phosphorylation | SYKRDCFSVGSNVDI EEECCCEECCCCEEE | 31.72 | 23403867 | |
| 127 | Phosphorylation | RDCFSVGSNVDIDFS CCCEECCCCEEEECC | 31.37 | 23403867 | |
| 129 | Ubiquitination | CFSVGSNVDIDFSGP CEECCCCEEEECCCC | 7.95 | 22817900 | |
| 131 | Ubiquitination | SVGSNVDIDFSGPTI ECCCCEEEECCCCCE | 5.12 | 21890473 | |
| 134 | Phosphorylation | SNVDIDFSGPTIYGW CCEEEECCCCCEEEE | 39.86 | 26552605 | |
| 137 | Phosphorylation | DIDFSGPTIYGWAVL EEECCCCCEEEEEEE | 30.29 | 26552605 | |
| 139 | Phosphorylation | DFSGPTIYGWAVLAF ECCCCCEEEEEEEEC | 14.75 | 26552605 | |
| 153 | Phosphorylation | FEGWLAGYQMSFDTA CHHHHHHEEEEHHHH | 8.74 | 26552605 | |
| 156 | Phosphorylation | WLAGYQMSFDTAKSK HHHHEEEEHHHHHHH | 12.40 | 26552605 | |
| 159 | Phosphorylation | GYQMSFDTAKSKLSQ HEEEEHHHHHHHHHC | 33.69 | 23403867 | |
| 161 | Ubiquitination | QMSFDTAKSKLSQNN EEEHHHHHHHHHCCC | 50.66 | 22817900 | |
| 162 | Phosphorylation | MSFDTAKSKLSQNNF EEHHHHHHHHHCCCC | 36.04 | 26437602 | |
| 162 | Ubiquitination | MSFDTAKSKLSQNNF EEHHHHHHHHHCCCC | 36.04 | 22817900 | |
| 163 | Acetylation | SFDTAKSKLSQNNFA EHHHHHHHHHCCCCC | 51.99 | 23954790 | |
| 163 | Ubiquitination | SFDTAKSKLSQNNFA EHHHHHHHHHCCCCC | 51.99 | 22817900 | |
| 163 | Neddylation | SFDTAKSKLSQNNFA EHHHHHHHHHCCCCC | 51.99 | 32015554 | |
| 163 | Malonylation | SFDTAKSKLSQNNFA EHHHHHHHHHCCCCC | 51.99 | 26320211 | |
| 163 (in isoform 1) | Ubiquitination | - | 51.99 | 21890473 | |
| 164 | Ubiquitination | FDTAKSKLSQNNFAL HHHHHHHHHCCCCCC | 9.10 | 22817900 | |
| 164 | Neddylation | FDTAKSKLSQNNFAL HHHHHHHHHCCCCCC | 9.10 | 32015554 | |
| 164 (in isoform 2) | Ubiquitination | - | 9.10 | 21890473 | |
| 165 | Phosphorylation | DTAKSKLSQNNFALG HHHHHHHHCCCCCCE | 34.30 | 26437602 | |
| 173 | Phosphorylation | QNNFALGYKAADFQL CCCCCCEEEEEEEEE | 9.78 | 30377224 | |
| 174 | Acetylation | NNFALGYKAADFQLH CCCCCEEEEEEEEEE | 34.99 | 23954790 | |
| 174 | Malonylation | NNFALGYKAADFQLH CCCCCEEEEEEEEEE | 34.99 | 26320211 | |
| 182 | Phosphorylation | AADFQLHTHVNDGTE EEEEEEEEECCCCCC | 35.79 | 29396449 | |
| 188 | Phosphorylation | HTHVNDGTEFGGSIY EEECCCCCCCCCHHH | 30.88 | 26437602 | |
| 195 | Phosphorylation | TEFGGSIYQKVNEKI CCCCCHHHHHHHHHC | 12.18 | 22817900 | |
| 197 | Ubiquitination | FGGSIYQKVNEKIET CCCHHHHHHHHHCCE | 30.01 | 29967540 | |
| 197 | Acetylation | FGGSIYQKVNEKIET CCCHHHHHHHHHCCE | 30.01 | 26051181 | |
| 198 | Ubiquitination | GGSIYQKVNEKIETS CCHHHHHHHHHCCEE | 7.07 | 29967540 | |
| 201 | Acetylation | IYQKVNEKIETSINL HHHHHHHHCCEEEEE | 40.41 | 26051181 | |
| 211 | Phosphorylation | TSINLAWTAGSNNTR EEEEEEEECCCCCCE | 18.61 | 23090842 | |
| 214 | Phosphorylation | NLAWTAGSNNTRFGI EEEEECCCCCCEEEE | 25.17 | 23090842 | |
| 217 | Phosphorylation | WTAGSNNTRFGIAAK EECCCCCCEEEEEEE | 31.46 | 23090842 | |
| 224 | Acetylation | TRFGIAAKYMLDCRT CEEEEEEEHHHHCCC | 23.36 | 25825284 | |
| 234 | Ubiquitination | LDCRTSLSAKVNNAS HHCCCCEEEEECCEE | 26.30 | 21890473 | |
| 236 | Malonylation | CRTSLSAKVNNASLI CCCCEEEEECCEEEE | 41.96 | 26320211 | |
| 236 | Acetylation | CRTSLSAKVNNASLI CCCCEEEEECCEEEE | 41.96 | 26051181 | |
| 241 | Phosphorylation | SAKVNNASLIGLGYT EEEECCEEEEECCCC | 23.73 | 28152594 | |
| 242 | Ubiquitination | AKVNNASLIGLGYTQ EEECCEEEEECCCCC | 3.15 | 21890473 | |
| 247 | Phosphorylation | ASLIGLGYTQTLRPG EEEEECCCCCCCCCC | 10.75 | 28152594 | |
| 248 | Phosphorylation | SLIGLGYTQTLRPGV EEEECCCCCCCCCCC | 17.18 | 28152594 | |
| 250 | Phosphorylation | IGLGYTQTLRPGVKL EECCCCCCCCCCCEE | 19.55 | 25159151 | |
| 258 | Phosphorylation | LRPGVKLTLSALIDG CCCCCEEEEEEEECC | 16.98 | 21712546 | |
| 260 | Phosphorylation | PGVKLTLSALIDGKN CCCEEEEEEEECCCC | 18.78 | 21712546 | |
| 266 | Acetylation | LSALIDGKNFSAGGH EEEEECCCCCCCCCC | 51.58 | 26051181 | |
| 266 | Ubiquitination | LSALIDGKNFSAGGH EEEEECCCCCCCCCC | 51.58 | 32015554 | |
| 266 | Malonylation | LSALIDGKNFSAGGH EEEEECCCCCCCCCC | 51.58 | 26320211 | |
| 266 (in isoform 1) | Ubiquitination | - | 51.58 | 21890473 | |
| 267 | Ubiquitination | SALIDGKNFSAGGHK EEEECCCCCCCCCCE | 41.45 | 21890473 | |
| 267 (in isoform 2) | Ubiquitination | - | 41.45 | 21890473 | |
| 274 | Ubiquitination | NFSAGGHKVGLGFEL CCCCCCCEEECEEEE | 41.07 | 32142685 | |
| 274 | Neddylation | NFSAGGHKVGLGFEL CCCCCCCEEECEEEE | 41.07 | 32015554 | |
| 274 | Acetylation | NFSAGGHKVGLGFEL CCCCCCCEEECEEEE | 41.07 | 26051181 | |
| 274 (in isoform 1) | Ubiquitination | - | 41.07 | 21890473 | |
| 275 | Ubiquitination | FSAGGHKVGLGFELE CCCCCCEEECEEEEE | 6.76 | 32142685 | |
| 275 | Neddylation | FSAGGHKVGLGFELE CCCCCCEEECEEEEE | 6.76 | 32015554 | |
| 275 (in isoform 2) | Ubiquitination | - | 6.76 | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of VDAC3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VDAC3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VDAC3_HUMAN !! | ||||||
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB01375 | Dihydroxyaluminium |
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT CYS-2; LYS-20; LYS-28; LYS-61;LYS-63 AND LYS-90, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-195, AND MASSSPECTROMETRY. | |